Human Vaccine Adjuvants Market Trends and Top Players 2020-2030
人类疫苗佐剂市场价值预计将从 2022 年的 15.7141 亿美元增长到 2030 年的 44.8923 亿美元。预计 2022 年至 2030 年期间人类疫苗佐剂市场的复合年增长率将达到 14.0%。
为了提高疫苗接种的有效性和安全性,对个性化疫苗的需求不断增加,导致人们对用于治疗癌症、传染病和自身免疫性疾病等疾病的个性化疫苗的兴趣增加,这可能仍是市场的主要趋势。
人类疫苗佐剂市场分析
人类疫苗佐剂市场的发展受到全球对免疫接种日益关注的推动,而慢性病负担的不断增加导致对可以预防或控制这些疾病的疫苗的需求不断增长。艾滋病毒、甲型肝炎、乙型肝炎、丙型肝炎和 HPV 是一些常见的传染病,可以通过接种疫苗来预防。然而,不断发展的制药行业预计将开发新的佐剂和疫苗,这可能会在未来几年创造充足的机会。此外,个性化疫苗的兴起趋势增加了研究机构之间的合作,并增加了研发活动,预计这将在预测期内扩大市场增长。
人类疫苗佐剂市场概况
人类疫苗佐剂市场的发展受到全球对免疫接种日益关注的推动,而慢性病负担的不断加重导致对可以预防或控制这些疾病的疫苗的需求不断增长。艾滋病毒、甲型肝炎、乙型肝炎、丙型肝炎和 HPV 是一些常见的传染病,可以通过接种疫苗来预防。此外,由于传染病发病率不断上升、医疗保健支出不断增加以及主要市场参与者的存在,北美在 2022 年占据了主要市场份额。由于传染病的流行率很高,以及政府通过免疫计划在亚太国家提供免费疫苗接种的举措,预计亚太地区将在未来几年以最高的复合年增长率增长。
定制研究以满足您的需求
我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。
人类疫苗佐剂市场:
复合年增长率(2022 - 2030 年)14.0%- 2022 年市场规模
15.7141 亿美元 - 2030 年市场规模
44.8923 亿美元
市场动态
- 对免疫接种的日益关注正在推动疫苗生产
- 慢性病负担加重导致疫苗需求不断增长
- 不断发展的制药行业创造了有利可图的增长机会
关键人物;主力;重要一员
- 诺华公司
- Dynavax技术公司
- 加拿大移动通信有限公司
- 塞皮克公司
- SPI制药公司
- 夏威夷生物技术公司
- 禾大国际有限公司
- 诺瓦瓦克斯公司
- Phibro 动物保健公司
- 创意生物实验室公司
区域概况
- 北美
- 欧洲
- 亚太
- 南美洲和中美洲
- 中东和非洲
市场细分
- 颗粒佐剂
- 乳化助剂
- 联合佐剂
- 其他的
- 流感
- 肝炎
- 人乳头状瘤病毒
- 制药和生物技术公司
- CMO 和 CRO
- 其他的
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
人类疫苗佐剂市场驱动因素和机遇
免疫接种日益受到青睐,市场前景看好
各国政府都认识到疫苗接种作为一种预防和控制慢性疾病的经济有效策略的重要性。根据世界卫生组织的数据,免疫接种目前每年可防止 350 万至 500 万人死于白喉、破伤风、百日咳、流感和麻疹等疾病。因此,各国政府正在实施免疫接种计划,以降低癌症、糖尿病、心血管疾病和呼吸系统疾病等疾病的发病率。这些计划通常针对特定人群,例如儿童、老年人和高危人群,以确保他们得到充分保护,免受这些慢性疾病的侵害。美国、印度和澳大利亚是拥有有效免疫接种计划的主要知名国家。例如,美国有儿童疫苗接种 (VFC) 计划,该计划于 1994 年开始实施,由联邦政府资助。同样,印度有普遍免疫计划 (UIP),目标是每年为 2670 万新生儿和 2900 万孕妇接种疫苗。联合国国际儿童紧急基金会 (UNICEF) 还提供免疫计划,提供疫苗以保护全球儿童免受危及生命的疾病的侵害。
不断发展的制药行业创造了有利可图的增长机会
美国是全球研发最密集的制药行业之一。根据欧洲制药工业和协会联合会 (EFPIA) 的数据,北美市场(美国和加拿大)仍是全球最大的市场,占 49.1% 的份额,远远领先于欧洲、中国和日本。美国是全球创新研发投资的领导者,在过去十年中,美国生产了全球一半以上的新分子。此外,根据 EFPIA 的数据,2021 年,北美占全球药品销售额的 49.1%,而欧洲占 23.4%。
同样,根据 EFPIA 的数据,2016-2021 年期间,巴西、中国和印度的制药业分别增长了 11.7%、6.7% 和 11.8%,而欧盟五大市场和美国市场的平均市场增长率分别为 5.8% 和 5.6%。此外,根据印度品牌资产基金会 (IBEF) 的数据,印度是全球制药业的主要和新兴参与者。该国是世界上最大的仿制药贸易国,占全球供应量的近 20%。它供应着全球疫苗需求的约 50%。国内制药业包括 3,000 家制药公司和约 10,500 个制造单位的网络。根据印度政府的官方数据,印度制药业的价值接近 500 亿美元,其中超过 250 亿美元来自出口。印度占世界仿制药出口的约 20%。随着行业不断发展和创新,对支持个性化疫苗开发的佐剂的需求不断增加,推动了人类疫苗佐剂市场的大幅增长和投资。因此,全球制药业的蓬勃发展很可能在未来几年为人类疫苗佐剂市场创造丰厚的增长机会。
人类疫苗佐剂市场报告细分分析
有助于得出人类疫苗佐剂市场分析的关键部分是类型、应用和最终用户。
- 根据类型,人类疫苗佐剂市场细分为乳剂佐剂、颗粒佐剂、组合佐剂和其他佐剂。颗粒佐剂部分在 2022 年占据了最大的市场份额。
- 根据应用,市场分为流感、肝炎、人乳头瘤病毒 (HPV) 和其他。流感领域在 2022 年占据了最大的市场份额。
- 就最终用户而言,市场分为制药和生物技术公司、CMO 和 CRO 以及其他。制药和生物技术公司部门在 2022 年占据了最大的市场份额。
人类疫苗佐剂市场份额按地区分析
人类疫苗佐剂市场报告的地理范围主要分为五个地区:北美、亚太、欧洲、中东和非洲、南美和中美。
北美占据了市场主导地位,美国在 2022 年占据了最大的市场份额。由于传染病发病率增加、医疗支出增加以及主要市场参与者的存在等因素,预计该国市场在预测期内将显着增长。根据美国医疗保险和医疗补助服务中心的数据,2021 年美国国家医疗保健支出增长了 2.7%,达到 4.3 万亿美元或每人 12,914 美元。卫生支出占全国 GDP 的 18.3%。根据美国卫生与公众服务部的数据,预计 2019 年至 2028 年期间国家卫生支出将以每年 5.4% 的速度增长,到 2028 年将达到 6.2 万亿美元。不断增加的卫生支出可能导致疫苗研发资金分配增加,从而刺激对人类疫苗佐剂的需求。由于传染病发病率高,且亚太国家政府通过免疫计划提供免费疫苗接种,预计未来几年亚太地区的复合年增长率将最高。
人类疫苗佐剂市场报告范围
报告属性 | 细节 |
---|---|
2022 年市场规模 | 15.7141亿美元 |
2030 年的市场规模 | 44.8923亿美元 |
全球复合年增长率(2022 - 2030 年) | 14.0% |
历史数据 | 2020-2021 |
预测期 | 2022-2030 |
涵盖的领域 | 按类型
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
人类疫苗佐剂市场新闻和最新发展
人类疫苗佐剂市场通过收集一级和二级研究后的定性和定量数据进行评估,其中包括重要的公司出版物、协会数据和数据库。以下列出了人类疫苗佐剂市场的一些发展情况:
- SPI Pharma Inc 与 Q-Vant Biosciences Inc 合作,此次合作将 Q-Vant 的技术与 SPI 的全球影响力和服务相结合。该协议包括投资 Q-Vant 专有的 100% 可持续 Q-SAP 技术的扩展,以及一项独家商业协议,以加速其皂苷佐剂在全球兽医和人类疫苗制剂中的应用。(来源:SPI Pharma,通讯,2023 年 10 月)
- Croda International Plc 与 Amyris 和 Botanical Solutions Inc (BSI) 合作,供应生物技术衍生的药用级角鲨烯,用于佐剂以增强免疫反应,并生产可持续的药用级 QS-21 疫苗佐剂,从而能够生产用于新疫苗开发的下一代佐剂系统。(来源:Croda International Plc,通讯,2023 年 5 月)
- 美国国防威胁降低局 (DTRA) 化学和生物防御 (CBD) 计划联合科学技术办公室 (JSTO) 已通过医学 CBRN [化学、生物、放射和核] 防御联盟 (MCDC) 要求 22-05“疫苗佐剂活性原型”授予 Ginkgo Bioworks, Inc. 和 SaponiQx, Inc. 团队一份为期 5 年的合同,总额高达 3100 万美元,包括计划选项,以发现和开发下一代疫苗佐剂。这将需要结合使用高通量经验和人工智能/机器学习方法,包括生成分子设计 (GMD),以开发出优质的新型皂苷佐剂。(Ginkgo Bioworks, Inc.,新闻稿,2024 年 2 月)
人类疫苗佐剂市场报告覆盖范围和交付成果
“人类疫苗佐剂市场规模和预测(2020-2030 年)”报告对以下领域进行了详细的市场分析:
- 人类疫苗佐剂市场规模及全球、区域和国家层面所有主要细分市场的预测范围
- 人类疫苗佐剂市场趋势以及市场动态,如驱动因素、限制因素和关键机遇
- 详细的 PEST/波特五力分析和 SWOT 分析
- 人类疫苗佐剂市场分析涵盖主要市场趋势、全球和区域框架、主要参与者、法规和最新市场发展
- 行业格局和竞争分析,涵盖市场集中度、热图分析、知名参与者以及人类疫苗佐剂市场的最新发展
- 详细的公司简介
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Growing focus on immunization globally followed by the increasing burden of chronic diseases has led to a growing demand for vaccines that can prevent or manage these conditions. HIV, Hepatitis A, B, C, and HPV are some of the common communicable disease which cen be prevented with the help of vaccinations are the driving factors impacting the Human vaccine adjuvants market
North America dominated the Human vaccine adjuvants market in 2023
Increasing demand for personalized vacccines to improve vaccination efficacy and safety, leading to increased interest in personalized vaccines for treating diseases such as cancer, infectious diseases, and autoimmune disorders are the future trends of the Human vaccine adjuvants.
The estimated value of the Human vaccine adjuvants market by 2031 is US$ 5.16 Bn
The expected CAGR of the Human vaccine adjuvants market is 14.3%
The leading players operating in the Human vaccine adjuvants market includes Novartis AG, Dynavax Technologies Corp, CSL Ltd, SEPPIC SA, SPI Pharma Inc, Hawaii Biotech Inc, Croda International Plc, Novavax Inc, Phibro Animal Health Corp, Creative Biolabs Inc among others
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.